Adamantinomatous Craniopharyngioma
Oncology·MeSH: Craniopharyngioma
Prevalence
5.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Adamantinomatous Craniopharyngioma?
There are 1 clinical trial targeting Adamantinomatous Craniopharyngioma tracked by BioSniper.
What is the prevalence of Adamantinomatous Craniopharyngioma?
The estimated prevalence of Adamantinomatous Craniopharyngioma is approximately 5.0 per 100,000 population.
Deep-dive into Adamantinomatous Craniopharyngioma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis